HSC commitment-associated epigenetic signature is prognostic in acute myeloid leukemia.

Acute myeloid leukemia (AML) is characterized by disruption of HSC and progenitor cell differentiation. Frequently, AML is associated with mutations in genes encoding epigenetic modifiers. We hypothesized that analysis of alterations in DNA methylation patterns during healthy HSC commitment and differentiation would yield epigenetic signatures that could be used to identify stage-specific prognostic subgroups of AML. We performed a nano HpaII-tiny-fragment-enrichment-by-ligation-mediated-PCR (nanoHELP) assay to compare genome-wide cytosine methylation profiles between highly purified human long-term HSC, short-term HSC, common myeloid progenitors, and megakaryocyte-erythrocyte progenitors. We observed that the most striking epigenetic changes occurred during the commitment of short-term HSC to common myeloid progenitors and these alterations were predominantly characterized by loss of methylation. We developed a metric of the HSC commitment–associated methylation pattern that proved to be highly prognostic of overall survival in 3 independent large AML patient cohorts, regardless of patient treatment and epigenetic mutations. Application of the epigenetic signature metric for AML prognosis was superior to evaluation of commitment-based gene expression signatures. Together, our data define a stem cell commitment–associated methylome that is independently prognostic of poorer overall survival in AML.

[1]  O. Abdel-Wahab,et al.  Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. , 2011, Cancer cell.

[2]  O. Abdel-Wahab,et al.  The role of mutations in epigenetic regulators in myeloid malignancies , 2012, Nature Reviews Cancer.

[3]  Joseph D Tariman,et al.  Myeloma Is Characterized by Stage-Specific Alterations in DNA Methylation That Occur Early during Myelomagenesis , 2013, The Journal of Immunology.

[4]  M. Jongen‐Lavrencic,et al.  Transition of highly specific microRNA expression patterns in association with discrete maturation stages of human granulopoiesis , 2011, British journal of haematology.

[5]  J. Greally,et al.  High Resolution Methylome Analysis Reveals Widespread Functional Hypomethylation during Adult Human Erythropoiesis* , 2013, The Journal of Biological Chemistry.

[6]  U. Steidl,et al.  Multi-parameter fluorescence-activated cell sorting and analysis of stem and progenitor cells in myeloid malignancies. , 2010, Best practice & research. Clinical haematology.

[7]  C. Glass,et al.  Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. , 2010, Molecular cell.

[8]  D. Tenen,et al.  Target proteins of C/EBPalphap30 in AML: C/EBPalphap30 enhances sumoylation of C/EBPalphap42 via up-regulation of Ubc9. , 2007, Blood.

[9]  Bas J. Wouters,et al.  Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling , 2009, Haematologica.

[10]  Kiran C. Bobba,et al.  The genetic basis of early T-cell precursor acute lymphoblastic leukaemia , 2012, Nature.

[11]  T. Jacks,et al.  Somatic activation of a conditional KrasG12D allele causes ineffective erythropoiesis in vivo. , 2006, Blood.

[12]  Mondira Kundu,et al.  Integrated genetic and epigenetic analysis of childhood acute lymphoblastic leukemia. , 2013, The Journal of clinical investigation.

[13]  A. Melnick,et al.  Methylome profiling reveals distinct alterations in phenotypic and mutational subgroups of myeloproliferative neoplasms. , 2013, Cancer research.

[14]  C. Steidl,et al.  Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations. , 2012, Blood.

[15]  Benjamin J. Raphael,et al.  Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. , 2013, The New England journal of medicine.

[16]  Christoph Bock,et al.  Global DNA Demethylation During Mouse Erythropoiesis in Vivo , 2011, Science.

[17]  P. Kenny,et al.  miR-21 mediates hematopoietic suppression in MDS by activating TGF-b signaling , 2013 .

[18]  M. Kawahara,et al.  H2.0-like homeobox regulates early hematopoiesis and promotes acute myeloid leukemia. , 2012, Cancer cell.

[19]  M. Bitzer,et al.  Inhibition of the TGF-beta receptor I kinase promotes hematopoiesis in MDS. , 2008, Blood.

[20]  S. Ben-Neriah,et al.  Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS. , 2012, Blood.

[21]  Angelo J. Canty,et al.  Stem cell gene expression programs influence clinical outcome in human leukemia , 2011, Nature Medicine.

[22]  S. Bohlander,et al.  C/EBPα regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations. , 2010, Blood.

[23]  Feng-Chun Yang,et al.  Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. , 2011, Blood.

[24]  D.,et al.  Regression Models and Life-Tables , 2022 .

[25]  P. Opolon,et al.  TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. , 2011, Cancer cell.

[26]  N. Socci,et al.  Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. , 2012, The New England journal of medicine.

[27]  J. Rowley,et al.  Leukaemogenesis: more than mutant genes , 2010, Nature Reviews Cancer.

[28]  D. Tenen,et al.  Ras Signaling Enhances the Activity of C/EBPα to Induce Granulocytic Differentiation by Phosphorylation of Serine 248* , 2002, The Journal of Biological Chemistry.

[29]  Quan Chen,et al.  An analytical pipeline for genomic representations used for cytosine methylation studies , 2008, Bioinform..

[30]  P. Lansdorp,et al.  Expression of Thy-1 on human hematopoietic progenitor cells , 1993, The Journal of experimental medicine.

[31]  Lucy Skrabanek,et al.  Genome-wide epigenetic analysis delineates a biologically distinct immature acute leukemia with myeloid/T-lymphoid features. , 2009, Blood.

[32]  M. Gönen,et al.  CD25 expression status improves prognostic risk classification in AML independent of established biomarkers: ECOG phase 3 trial, E1900. , 2012, Blood.

[33]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[34]  Fabien Campagne,et al.  DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia. , 2010, Cancer cell.

[35]  Jiwang Zhang,et al.  Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemia. , 2012, Cancer cell.

[36]  D. Schübeler.  Epigenetic Islands in a Genetic Ocean , 2012, Science.

[37]  Irving L. Weissman,et al.  Prospective isolation of human clonogenic common myeloid progenitors , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[38]  R. Verhaak,et al.  Prognostically useful gene-expression profiles in acute myeloid leukemia. , 2004, The New England journal of medicine.

[39]  J. Jelinek,et al.  Dnmt3a Is Essential for Hematopoietic Stem Cell Differentiation , 2011 .

[40]  J. Licht,et al.  Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. , 2010, Cancer cell.

[41]  Irving L. Weissman,et al.  A comprehensive methylome map of lineage commitment from hematopoietic progenitors , 2010, Nature.

[42]  Reid F. Thompson,et al.  Late-replicating heterochromatin is characterized by decreased cytosine methylation in the human genome. , 2011, Genome research.

[43]  Christian Steidl,et al.  Essential role of Jun family transcription factors in PU.1 knockdown–induced leukemic stem cells , 2006, Nature Genetics.

[44]  A. Bird,et al.  CpG islands and the regulation of transcription. , 2011, Genes & development.

[45]  D. Gao,et al.  Integrated genomic analyses identify WEE1 as a critical mediator of cell fate and novel therapeutic target in acute myeloid leukemia , 2011, Leukemia.

[46]  Daniel G Tenen,et al.  Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. , 2010, Blood.

[47]  Zachary D. Smith,et al.  DNA methylation dynamics during in vivo differentiation of blood and skin stem cells. , 2012, Molecular cell.

[48]  C. Croce,et al.  MicroRNAs in normal and malignant hematopoiesis , 2008, Current opinion in hematology.

[49]  R. Verhaak,et al.  A distal single nucleotide polymorphism alters long-range regulation of the PU.1 gene in acute myeloid leukemia. , 2007, The Journal of clinical investigation.

[50]  N. Zeleznik-Le,et al.  miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia , 2012, Nature Communications.

[51]  Kenny Q. Ye,et al.  An Integrative Genomic and Epigenomic Approach for the Study of Transcriptional Regulation , 2008, PloS one.

[52]  O. Abdel-Wahab,et al.  Aberrant Epigenetic and Genetic Marks Are Seen in Myelodysplastic Leukocytes and Reveal Dock4 as a Candidate Pathogenic Gene on Chromosome 7q* , 2011, The Journal of Biological Chemistry.

[53]  M. Bitzer,et al.  Reduced SMAD7 leads to overactivation of TGF-beta signaling in MDS that can be reversed by a specific inhibitor of TGF-beta receptor I kinase. , 2011, Cancer research.

[54]  Reid F. Thompson,et al.  High-resolution genome-wide cytosine methylation profiling with simultaneous copy number analysis and optimization for limited cell numbers , 2009, Nucleic acids research.

[55]  M. Patnaik,et al.  Anthracycline dose intensification in acute myeloid leukemia. , 2009, The New England journal of medicine.

[56]  Kenny Q. Ye,et al.  Comparative isoschizomer profiling of cytosine methylation: the HELP assay. , 2006, Genome research.

[57]  Ash A. Alizadeh,et al.  Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia. , 2010, JAMA.

[58]  I. Weissman,et al.  Isolation of a candidate human hematopoietic stem-cell population. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[59]  R. Jaenisch,et al.  DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction , 2009, Nature Genetics.

[60]  Ulrich Mansmann,et al.  Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative study. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[61]  Jelle J. Goeman,et al.  A global test for groups of genes: testing association with a clinical outcome , 2004, Bioinform..

[62]  G. Reifenberger,et al.  IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics , 2012, Nature.